M&A Deal Summary

Sanofi Acquires Bioverativ

On January 22, 2018, Sanofi acquired life science company Bioverativ for 11.6B USD

Acquisition Highlights
  • This is Sanofi’s 10th transaction in the Life Science sector.
  • This is Sanofi’s 2nd largest (disclosed) transaction.
  • This is Sanofi’s 11th transaction in the United States.
  • This is Sanofi’s 3rd transaction in Massachusetts.

M&A Deal Summary
Date 2018-01-22
Target Bioverativ
Sector Life Science
Buyer(s) Sanofi
Deal Type Add-on Acquisition
Deal Value 11.6B USD
Advisor(s) Guggenheim Securities
J.P. Morgan Securities (Financial)
Paul, Weiss, Rifkind, Wharton & Garrison (Legal)

Target

Bioverativ

Waltham, Massachusetts, United States
Bioverativ, Inc. is a global biotechnology company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sanofi

Paris, France
Category Company
Founded 1994
Sector Life Science
Employees86,088
Revenue 46.4B EUR (2023)
DESCRIPTION

Sanofi is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi was founded in 1994 and is based in Paris, France.

DEAL STATS #
Overall 19 of 27
Sector (Life Science) 10 of 18
Type (Add-on Acquisition) 14 of 21
State (Massachusetts) 3 of 4
Country (United States) 11 of 16
Year (2018) 1 of 2
Size (of disclosed) 2 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-04-19 Winthrop Pharma Senegal

Dakar, Senegal

WPS is a significant operator in the pharmaceuticals sector in French-speaking sub-Saharan Africa (FSSA). MédiS' acquisition includes a 34,000m² manufacturing facility in the Rufisque district of Dakar, Senegal.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-02-01 Sanofi SA - Leukine

Paris, France

Sanofi SA - Leukine is an immuno-stimulant that promotes the growth and activation of a broad range of white blood cells important in activating the body's immune response to fight infections.

Sell -
Mergr

Product

Company

Legal